Navigation Links
Manzo Pharmaceuticals, LLC Unveils the Unique Health Benefits of Lacto-Freedom Probiotic
Date:2/9/2017

People with lactose sensitivity will now receive some relief as Ken Manzo, the founder of Manzo Pharmaceuticals LLC, unveiled the health benefits of the company’s new and unique patented supplement “Lacto-Freedom Probiotic.” Lactose sensitivity is a common health challenge which results from the inability to properly digest lactose, a sugar found in milk and other milk products. This is caused by the deficiency of lactase, an enzyme in the human body which is normally produced by the cells lining the small intestine.

After consuming food that contains lactose, people with lactose sensitivity regularly experience abdominal pain, bloating, gas, diarrhea, and nausea. The discomfort can range from mild to severe, depending on the quantity of lactose consumed and the tolerance level of the person.

To provide relief to the people with lactose sensitivity, Manzo Pharmaceuticals, LLC., along with Celprogen, Inc., researched, produced, and made available its unique patented supplement “Lacto-Freedom Probiotic.” This nutritional supplement which is specifically designed for people who have difficulty tolerating lactose assists in the digestion of foods containing lactose thereby relieving users from the discomfort that is associated with lactose sensitivity.

As explained by Ken Manzo, “Lacto-Freedom Probiotic is consumed for 7 days and stays in the intestines and produces the enzyme lactase which aids in the digestion of lactose thereby eliminating or greatly reducing the discomfort associated with lactose sensitivity. The use of Lacto-Freedom Probiotic has allowed lactose sensitive people to enjoy milk and other dairy products without experiencing the digestive discomfort resulting in many positive customer reviews.”

Now lactose sensitive people, who have difficulty tolerating dietary lactose, are no longer limited to the two options of either avoiding foods containing lactose or taking lactase supplements at the beginning of every lactose-containing meal. The probiotic is more economical and convenient than taking lactase tablets as the effects of the supplement last for months when consumed only for 7 days.

Click here to see a video on "How Lacto-Freedom Works"

Lacto-Freedom Probiotic:

Taken for only 7 days and effect and relief last for months.
Aids in the digestion of lactose-containing foods.
Patented, clinically tested.
More convenient and more economical than taking lactase tablets or consuming lactose-free foods.

Click here to watch a video on "How Lacto-Freedom Probiotic Works in the Intestines."

For more information about Lactose freedom probiotic and to purchase, visit: LactoFreedom.com

Follow us on Facebook /Manzopharma

About Manzo Pharmaceuticals, LLC
Manzo Pharmaceuticals is a private firm established by Ken Manzo R. Ph., and is located in Pike County, Pennsylvania. Ken is the inventor of the patented Lacto-Freedom Probiotic and co-developed it with Celprogen, Inc., a biotech company in California. Ken Manzo is a licensed pharmacist in New York, New Jersey, and Pennsylvania. For further inquiries contact Ken at manzopharma(at)outlook(dot)com

Read the full story at http://www.prweb.com/releases/2017/02/prweb14055225.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Manzo Pharmaceuticals, LLC Announced That the Name of Their Main Product Lacto-Freedom Was Accepted as a Registered Trademark by the US Patent and Trademark Office
2. Kirk Manzo of The Manzo Group Announces New Affiliation with The John Maxwell Team
3. National Association of Professional Women Inducts Usha R. Patel, Senior Patent Agent at Boehringer Ingelheim Pharmaceuticals, Inc., Into its VIP Woman of the Year Circle
4. National Association of Professional Women Inducts Linda M. Vrasich, M.B.A., DEA Coordinator of Morton Grove Pharmaceuticals, Into its VIP Woman of the Year Circle
5. Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc.
6. National Association of Professional Women Announces Donna Ames, Sr. Manager, Clinical Project Lead at Alexion Pharmaceuticals, a 2014 Professional Woman of the Year
7. BabelBark Unveils BabelVet at NAVC to Help Regional and Independent Veterinary Hospitals Compete in an Ever-Changing Landscape
8. Taza Agua Unveils New Innovative Water Bottles to Enhance K-Cup Drinking Experience
9. Pennsylvania Addiction Treatment Center Unveils New Website on New Domain
10. iaedp™ Unveils Spanish Language Schedule for 2017 Symposium
11. Compass Health Brands Unveils Seven New Pain Management Devices at CES 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2018)... ... 2018 , ... Caring.com, the nation’s most visited website for senior living reviews, ... to its list of top medical alert systems for 2019. The medical alert provider ... one of fourteen companies that qualified for the list based on its demonstration of ...
(Date:12/6/2018)... SAN DIEGO (PRWEB) , ... December 06, 2018 ... ... alongside Mike Wilson, Medicare Analytic Consultant Senior of Blue Cross and Blue Shield ... Measures are Interrelated” on Tuesday, December 11, 2018 at 2:15pm PT at the ...
(Date:12/5/2018)... , ... December 05, 2018 ... ... advancing patient and family engagement with the use of the Precision Virtual ... technology provides Children’s National’s world-renowned neurosurgeons and physicians with a never-before view ...
(Date:12/5/2018)... , ... December 05, 2018 , ... Since PermaLip™ ... ruptures. The implants are invisible to the naked eye, ensuring a natural look. “I ... and that there are no signs of implant visibility,” says Dr. Jessica Kulak, double ...
(Date:12/5/2018)... ... , ... You can now experience two cutting edge Oregon brands at the ... in the cannabis industry with several brands including Sticks and Cabana ... award winning , botanical terpene company that focuses on using terpenes from non-cannabis sources ...
Breaking Medicine News(10 mins):
(Date:11/29/2018)... ... 29, 2018 , ... More than 205,000 individuals have signed the 4th Annual ... significantly increase funding for type 1 diabetes cure research after spending on such initiatives ... An estimated two million Americans are affected by type 1 diabetes, and about half ...
(Date:11/28/2018)... N.Y. (PRWEB) , ... November 28, 2018 , ... Satin ... presented a donation of $2,400 to Hudson Valley Honor Flight on Sept 28th, 2018 ... recent sales incentive campaign and presented to HVHF by Kevin O’Reilly, Founder and CEO ...
(Date:11/28/2018)... WOODLANDS, Texas (PRWEB) , ... November 28, 2018 ... ... from Rigaku Corporation has been published and is available to view ... concentrating on single crystal X-ray diffraction, published by Rigaku Oxford Diffraction , ...
Breaking Medicine Technology: